Skip to main content

Seaport Therapeutics, Inc.

SPTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002042347

In the last 90 days, Seaport Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 73 institutions reported holding it in 13F filings for Q3 2026, worth $766.9M in total; no superinvestor holds it.

SEC filings

10-K, 10-Q, 8-K, 20-F and 40-F reports Seaport Therapeutics, Inc. filed with the SEC, newest first.

Livermore lists each filing's form, 8-K items and dates only. To read a filing, open it on SEC.gov; an 8-K's press release or other attachments, such as exhibit 99.1 for Item 2.02, are in the filing index.

SEC filings by Seaport Therapeutics, Inc.
FiledForm8-K itemsPeriodDocumentFiling index
Nov 2, 202610-Q–Sep 30, 2026SECIndex
Nov 2, 20268-K2.029.01Nov 2, 2026SECIndex
Aug 3, 202610-Q–Jun 30, 2026SECIndex
Aug 3, 20268-K2.029.01Aug 3, 2026SECIndex
Jun 8, 202610-Q–Mar 31, 2026SECIndex
Jun 8, 20268-K2.029.01Jun 8, 2026SECIndex
May 4, 20268-K5.039.01May 4, 2026SECIndex